Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XUE Study of allopurinol effects on platelet function in aspirin-resistant diabetic patients with stable coronary disease
2011-000619-16Phase 3Completed
- Sponsor
- Fundación para la Investigación Biomédica del Hospital Clínico San Carlos
- Start
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of allopurinol in thrombocytopathy, sponsored by Fundación para la Investigación Biomédica del Hospital Clínico San Carlos. Primary endpoint: Change in platelet functionality by PFA-100 after allopurinol treatment. Started Nov 2011; status: completed.
02
Drugs
allopurinol
03
Conditions
thrombocytopathy
Beyond the preview
Go deeper on 2011-000619-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000619-16.